Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Freeport-McMoran
FCX
|
+$302M |
| 2 |
Advanced Micro Devices
AMD
|
+$270M |
| 3 |
Cardinal Health
CAH
|
+$257M |
| 4 |
Adobe
ADBE
|
+$221M |
| 5 |
Visa
V
|
+$218M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$257M |
| 2 |
Bank of America
BAC
|
+$245M |
| 3 |
Stanley Black & Decker
SWK
|
+$240M |
| 4 |
Coca-Cola
KO
|
+$232M |
| 5 |
Cisco
CSCO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.38% |
| 2 | Healthcare | 15.51% |
| 3 | Financials | 12.11% |
| 4 | Consumer Discretionary | 11.09% |
| 5 | Industrials | 8.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
AbCellera Biologics
ABCL
$1.62B
| $265K | ﹤0.01% |
+23,877
| New | +$202K |
|
1252
Fortuna Silver Mines
FSM
$2.59B
| $263K | ﹤0.01% |
100,000
| – | – |
|
1253
VEON
VEON
$3.53B
| $256K | ﹤0.01% |
22,957
+15,947
| +227% | +$213K |
|
1254
Qualys
QLYS
$4.84B
| $252K | ﹤0.01% |
2,088
-171
| -8% | -$22.4K |
|
1255
Kforce
KFRC
$983M
| $250K | ﹤0.01% |
4,052
+18
| +0.4% | +$1.23K |
|
|
SA
1256
Seabridge Gold
SA
$2.8B
| $249K | ﹤0.01% |
20,000
| – | – |
|
1257
Medpace
MEDP
$16.8B
| $247K | ﹤0.01% |
1,668
-162
| -9% | -$23.5K |
|
1258
Enel Chile
ENIC
$5.96B
| $244K | ﹤0.01% |
215,846
-1,074
| -0.5% | -$1.48K |
|
1259
Cipher Digital
CIFR
$9.47B
| $242K | ﹤0.01% |
151,023
+45,232
| +43% | +$110K |
|
1260
Invesco China Technology ETF
CQQQ
$2.95B
| $241K | ﹤0.01% |
5,250
+2,200
| +72% | +$99.3K |
|
1261
DT Midstream
DTM
$14.9B
| $240K | ﹤0.01% |
5,031
-786
| -14% | -$42.9K |
|
1262
Vanguard Health Care ETF
VHT
$18.2B
| $233K | ﹤0.01% |
993
| – | – |
|
1263
Valley National Bancorp
VLY
$7.93B
| $232K | ﹤0.01% |
22,895
| – | – |
|
1264
Aurora
AUR
$11.7B
| $229K | ﹤0.01% |
113,844
+45,210
| +66% | +$166K |
|
1265
Amkor Technology
AMKR
$16.1B
| $227K | ﹤0.01% |
13,386
+1,018
| +8% | +$19.3K |
|
1266
QuidelOrtho
QDEL
$1.09B
| $223K | ﹤0.01% |
2,250
+175
| +8% | +$17.8K |
|
1267
Interparfums
IPAR
$3.92B
| $211K | ﹤0.01% |
2,988
| – | – |
|
1268
Lattice Semiconductor
LSCC
$17.6B
| $211K | ﹤0.01% |
+4,158
| New | +$207K |
|
|
KRTX
1269
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $211K | ﹤0.01% |
1,603
+379
| +31% | +$43.6K |
|
|
SKE
1270
Skeena Resources
SKE
$3.36B
| $210K | ﹤0.01% |
45,000
-5,000
| -10% | -$41.9K |
|
1271
Coeur Mining
CDE
$15.6B
| $207K | ﹤0.01% |
75,000
-335,608
| -82% | -$1.32M |
|
1272
IAMGOLD
IAG
$8.47B
| $207K | ﹤0.01% |
150,000
-1,035,512
| -87% | -$2.61M |
|
|
ZIMV
1273
DELISTED
ZimVie
ZIMV
| $206K | ﹤0.01% |
11,854
+11,800
| +21,852% | +$260K |
|
1274
iRhythm Holdings
IRTC
$3.59B
| $201K | ﹤0.01% |
1,468
-182
| -11% | -$24.1K |
|
1275
Sarepta Therapeutics
SRPT
$1.66B
| $198K | ﹤0.01% |
2,404
| – | – |
|
Similar funds
Amundi's Q2 2022 Portfolio in Review
As of Q2 2022, Amundi held 1,750 positions worth $125B, down 16% from $148B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Amundi's Q2 2022 filing shows 104 new, 631 increased, 657 reduced and 91 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 188,190 shares worth $71.5M. The largest sale was Procter & Gamble, an estimated $257M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Amundi's largest Q2 2022 buy was iShares Core S&P 500 ETF: 188,190 shares worth $71.5M.
- Amundi added most to Freeport-McMoran in Q2 2022, an estimated $302M increase.
- Amundi's biggest Q2 2022 reduction was Procter & Gamble, cutting an estimated $257M.
- Amundi fully exited Cerner Corp in Q2 2022, selling an estimated $152M.
- Amundi's ten largest holdings make up 18% of its $125B portfolio in Q2 2022.
- Amundi opened 104 new positions and closed 91 in Q2 2022.
- Amundi's portfolio value fell 16% quarter-over-quarter to $125B.
Based on Amundi's 13F filing for Q2 2022, filed 15 Aug 2022.